BioMarin Pharmaceutical Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2017
Total Assets: $4.63B
Liabilities Breakdown FY2017
Total Liabilities: $1.82B
Asset Breakdown
Total Assets: $4.63B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $598.0M | 12.9% |
| Accounts Receivable | $261.4M | 5.6% |
| Inventory | $475.8M | 10.3% |
| Property, Plant & Equipment | $896.7M | 19.4% |
| Goodwill | $197.0M | 4.3% |
| Intangible Assets | $517.5M | 11.2% |
| Other Assets | $1.69B | 36.4% |
Liabilities Breakdown
Total Liabilities: $1.82B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.82B | 100.0% |